Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.8M; returns 1 day -6.0%, 1 week -12.0%, 1 year -91.1%.

TScan Therapeutics Inc. (TCRX) is a clinical-stage biotechnology company focused on developing T-cell receptor (TCR)-engineered T cell (TCR-T) therapies for treating cancer patients. Their approach involves identifying high-affinity TCRs that recognize intracellular tumor antigens presented on cancer cells.

Groups TCRX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Oncology
• Hematologic Malignancies
• Cancer Therapeutics
• Clinical Stage
• Life Sciences
• Immunotherapy

TCRX financial model: income statement, cash flow and balance sheet